Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Paliperidone Palmitate (3 Month) 819 Mg/2.63 Ml Intramuscular Syringe (CDM 172818) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved June 27, 2026 , from http://ppman.hank.ai/transparency/procedure/172818/by-state?code_type=CDM
“Paliperidone Palmitate (3 Month) 819 Mg/2.63 Ml Intramuscular Syringe (CDM 172818) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/172818/by-state?code_type=CDM. Accessed
June 27, 2026 .
“Paliperidone Palmitate (3 Month) 819 Mg/2.63 Ml Intramuscular Syringe (CDM 172818) by State,” HANK Price Transparency ,
accessed June 27, 2026 ,
http://ppman.hank.ai/transparency/procedure/172818/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
172818 — Paliperidone Palmitate (3 Month) 819 Mg/2.63 Ml Intramuscular Syringe
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$10,584
National median
$3,658 – $13,069
IQR (p25 – p75)
3
hospitals filing
2
states
Walking in without insurance?
Cash / self-pay price
Cash median
$4,445
vs. negotiated
-58.0%
Hospitals reporting
8
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 172818 (CDM), with interquartile range
State Median p25 p75
NE $13,069 $12,932 $13,207
MI $7,091 $3,493 $10,584